NCT06648213

Brief Summary

In this study, investigators aimed to apply an individual structured therapy protocol within the framework of neurodevelopmental therapy principles in early premature infants hospitalized in the neonatal intensive care unit and to examine its effect on the motor development of infants.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 16, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 18, 2024

Completed
12 days until next milestone

Study Start

First participant enrolled

October 30, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 5, 2025

Completed
27 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 2, 2025

Completed
Last Updated

November 24, 2025

Status Verified

November 1, 2025

Enrollment Period

7 months

First QC Date

October 16, 2024

Last Update Submit

November 19, 2025

Conditions

Keywords

individualized therapy, infant development, neonatal intensive care unit, early preterm

Outcome Measures

Primary Outcomes (2)

  • General Movements

    GMs movements are a complex set of movements involving the whole body of the baby, which start to be observed from the 9th week of intrauterine life, change shape after the second month of the postterm period and can be monitored until the 20th week in corrected form. GMA is a valid and reliable analysis used to determine brain dysfunctions in preterm, term and postterm infants up to the 20th week. GMA analysis can be performed during sleep or wakefulness in preterm infants.

    For GMA analysis in our study, a 3-5 min video of the babies lying supine outside the incubator will be taken. The videos will be recorded at 34th week and 36th week.

  • Hammersmith Neonatal Neurological Examination (HNNE)

    HNNE is a rapid, practical and easy-to-apply assessment method. It can be used in the assessment of term and preterm babies of different ages within the neonatal period. It is one of the standard methods used to predict the risk of cerebral palsy.

    The HNNE short form will be applied at 34th week and 36th week.

Secondary Outcomes (1)

  • Weigh

    Three times a week between 34-36th weeks.

Study Arms (2)

Individualized Physiotherapy

OTHER

Therapy group: In addition to routine care, they will be arranged according to the needs of the baby in the form of positioning, hand contacts, passive and active movement of the arms and legs for the development of movement, sensory stimuli around the mouth for oral motor organisation. Neurodevelopmental-based application will be applied three days a week, once a day for 10-15 minutes, from the 34th week until 36th week when vital signs are stable.

Other: Physiotherapy

Control

NO INTERVENTION

Control group: They will be monitored by performing routine care and positioning.

Interventions

Therapy group: In addition to routine care, they will be arranged according to the needs of the baby in the form of positioning, hand contacts, passive and active movement of the arms and legs for the development of movement, sensory stimuli around the mouth for oral motor organisation. Neurodevelopmental-based application will be applied three days a week, once a day for 10-15 minutes, from the 34th week until 36th week when vital signs are stable.

Individualized Physiotherapy

Eligibility Criteria

AgeUp to 34 Weeks
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Hospitalised in the neonatal intensive care unit,
  • Born before 34 weeks of gestation
  • medium and low-risk babies

You may not qualify if:

  • \. Diagnosed neurological, neuromuscular or genetic disease 2. Congenital anomalies 3. Newborns whose parents did not consent to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gülhane Hospital

Ankara, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Premature Birth

Interventions

Physical Therapy Modalities

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Intervention Hierarchy (Ancestors)

TherapeuticsRehabilitation

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PT, PhD

Study Record Dates

First Submitted

October 16, 2024

First Posted

October 18, 2024

Study Start

October 30, 2024

Primary Completion

June 5, 2025

Study Completion

July 2, 2025

Last Updated

November 24, 2025

Record last verified: 2025-11

Locations